These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 19187619)

  • 41. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
    Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y; Takemura G; Kosai K; Yuge K; Nagano S; Esaki M; Goto K; Takahashi T; Hayakawa K; Koda M; Kawase Y; Maruyama R; Okada H; Minatoguchi S; Mizuguchi H; Fujiwara T; Fujiwara H
    Circulation; 2003 May; 107(19):2499-506. PubMed ID: 12695295
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V; Woo YJ; Pirolli TJ; Bish LT; Berry MF; Burdick J; Gardner TJ; Sweeney HL
    J Card Surg; 2005; 20(1):93-101. PubMed ID: 15673421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of phytoestrogen genistein on myocardial ischemia/reperfusion injury and apoptosis in rabbits.
    Ji ES; Yue H; Wu YM; He RR
    Acta Pharmacol Sin; 2004 Mar; 25(3):306-12. PubMed ID: 15000883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction.
    Balsam LB; Kofidis T; Robbins RC
    J Surg Res; 2005 Apr; 124(2):194-200. PubMed ID: 15820248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive Reduction in Myocyte Autophagy After Myocardial Infarction in Rabbits: Association with Oxidative Stress and Left Ventricular Remodeling.
    Chi RF; Wang JP; Wang K; Zhang XL; Zhang YA; Kang YM; Han XB; Li B; Qin FZ; Fan BA
    Cell Physiol Biochem; 2017; 44(6):2439-2454. PubMed ID: 29268264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
    Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
    J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of apoptosis in the amygdala by an A2A adenosine receptor agonist following myocardial infarction.
    Boucher M; Wann BP; Kaloustian S; Cardinal R; Godbout R; Rousseau G
    Apoptosis; 2006 Jul; 11(7):1067-74. PubMed ID: 16832713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
    Leor J; Tuvia S; Guetta V; Manczur F; Castel D; Willenz U; Petneházy O; Landa N; Feinberg MS; Konen E; Goitein O; Tsur-Gang O; Shaul M; Klapper L; Cohen S
    J Am Coll Cardiol; 2009 Sep; 54(11):1014-23. PubMed ID: 19729119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function.
    Xing W; Yan W; Fu F; Jin Y; Ji L; Liu W; Wang L; Lv A; Duan Y; Zhang J; Zhang H; Gao F
    Apoptosis; 2009 Sep; 14(9):1050-60. PubMed ID: 19590963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antioxidant activity contributes to flavonol cardioprotection during reperfusion of rat hearts.
    Qin CX; Williams SJ; Woodman OL
    Free Radic Biol Med; 2011 Oct; 51(7):1437-44. PubMed ID: 21801832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propofol limits rat myocardial ischemia and reperfusion injury with an associated reduction in apoptotic cell death in vivo.
    Jin YC; Kim W; Ha YM; Shin IW; Sohn JT; Kim HJ; Seo HG; Lee JH; Chang KC
    Vascul Pharmacol; 2009; 50(1-2):71-7. PubMed ID: 18996224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of emulsified isoflurane on haemodynamics and cardiomyocyte apoptosis in rats with myocardial ischaemia.
    Hu ZY; Liu J
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):776-83. PubMed ID: 19207725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction.
    Matsusaka H; Kinugawa S; Ide T; Matsushima S; Shiomi T; Kubota T; Sunagawa K; Tsutsui H
    J Cardiovasc Pharmacol; 2006 Sep; 48(3):95-102. PubMed ID: 17031262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opposite effects of amlodipine and enalapril on infarct collagen and remodelling during healing after reperfused myocardial infarction.
    Jugdutt BI; Musat-Marcu S
    Can J Cardiol; 2000 May; 16(5):617-25. PubMed ID: 10833541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the early administration of losartan on the functional and morphological aspects of postmyocardial infarction ventricular remodeling in rabbits.
    González GE; Palleiro J; Monroy S; Pérez S; Rodríguez M; Masucci A; Gelpi RJ; Morales C
    Cardiovasc Pathol; 2005; 14(2):88-95. PubMed ID: 15780800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling.
    Zeng L; Hu Q; Wang X; Mansoor A; Lee J; Feygin J; Zhang G; Suntharalingam P; Boozer S; Mhashilkar A; Panetta CJ; Swingen C; Deans R; From AH; Bache RJ; Verfaillie CM; Zhang J
    Circulation; 2007 Apr; 115(14):1866-75. PubMed ID: 17389266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.